Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 13, 2013 - Issue sup1
Submit an article Journal homepage
261
Views
22
CrossRef citations to date
0
Altmetric
Symposium Paper

A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany

Peter Flachenecker Neurological Rehabilitation Center Quellenhof, Kuranlagenallee 2, 75323 Bad Wildbad, Germany. [email protected]
Pages 15-19 | Published online: 09 Jan 2014

References

  • Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult. Scler.10, 589–595 (2004).
  • Perez J. Combined cannabinoid therapy via an oromucosal spray. Drugs Today (Barc.)42, 495–503 (2006).
  • Collin C, Davies P, Mutiboko IK, Ratcliffe S. Sativex spasticity in MS Study Group. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur. J. Neurol.14, 290–296 (2007).
  • Collin C, Ehler E, Waberzinek G et al. A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol. Res.32, 451–459 (2010).
  • Wade DT, Collin C, Stott C, Duncombe P. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult. Scler.16, 707–714 (2010).
  • Novotna A, Mares J, Ratcliffe S et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur. J. Neurol.18, 1122–1131 (2011).
  • Silverman SL. From randomized controlled trials to observational studies. Am. J. Med.122, 114–120 (2009).
  • Zettl U, Henze T, Pfiffner C, Vila Silvan C, Flachenecker P. Effectiveness of Sativex® in multiple sclerosis spasticity. First data from a large observational study in Germany. Presented at: the European Committee for Treatment and Research in Multiple Sclerosis. Lyon, France, 10 October 2012 (Poster P568).
  • Flachenecker P, Henze T, Hengsbach M, Ehlken B, Zettl UK. Spasticity in multiple sclerosis – a cross-sectional survey in Germany. Mult. Scler.18, S21 (2012).
  • Flachenecker P, Zettl U, Essner U, Henze T. Drug treatment of spasticity in multiple sclerosis – a cross-sectional survey in Germany. Presented at: the European Committee for Treatment and Research in Multiple Sclerosis. Lyon, France, 10 October 2012 (Poster P1029).
  • Slof J, Gras A. Sativex® in multiple sclerosis spasticity: a cost–effectiveness model. Expert Rev. Pharmacoecon. Outcomes Res.12(4), 525–538 (2012).
  • Wade DT, Makela PM, House H, Bateman C, Robson P. Long-term use of cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult. Scler.12, 639–645 (2006).
  • Raftery J. Review of NICE’s recommendations, 1999–2005. Br. Med. J.332, 1266–1268 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.